Adequan® I.M.

FDA-approved for the treatment of non-infectious degenenerative and/or traumatic joint dysfunction

Requires a veterinarian's prescription 
NOTE:  At this time Adequan is ONLY available to clients of Craig T. Roberts, DVM, Inc.  We are working on securing licensing to fill prescriptions from other veterinarians in the near future.  Thanks for your patience.

Active ingredient: Polysulfated Glycosaminoglycan (PSGAG)
Form: Intramuscular (IM) injection

Adequan® I.M. is FDA-approved for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.  Adequan® IM is available in 5 mL vials, packaged individually or in boxes of 7, or as a 50 mL multi-dose vial (all vials contain 500 mg of PSGAG per 5 mL).

Each vial contains 500 mg PSGAG in Water for Injection USP. Sodium Hydroxide and/or Hydrochloric Acid added when necessary to adjust pH. Sodium Chloride may be added to adjust tonicity.

The recommended dose of Adequan® I.M. in horses is 500 mg every 4 days for 28 days intramuscularly. The injection site must be thoroughly cleansed prior to injection. Do not mix Adequan® I.M. with other drugs or solvents.